On the Horizon: Studies have Shown that Over 80% Herpes Infections are Asymptomatic

Herpes virus is a ubiquitous pathogen whose primary infections are usually asymptomatic. There are two types of Herpes Simplex virus (HSV): HSV-1 is known to cause orofacial disease such as cold sores; while HSV-2 causes genital infections. Over 80% of the herpes infections are asymptomatic; symptomatic infections are presented with blistering sores, pain during urination, swollen lymph nodes, and fever. Period of latency and mode of reactivation of HSV is yet unclear.

Studies have shown that over 80% herpes infections are asymptomatic, which makes their timely diagnosis challenging. In cases where symptoms are present, they appear in the form of blistering sores, fever, swelling in the lymph nodes, and pain during urination. Because of this, highly accurate and sensitive diagnostic tests are the only tool available to physicians suspecting HSV infections. The global herpes marker testing market currently features four types of HSV biomarker tests – antigen tests, cell culture tests, polymerase chain reaction (PCR), and antibody tests. The report on the herpes marker testing market studies the uptake of each of these test types in detail to emerge with details such as: the most widely-used test currently, the future shares of herpes marker tests, innovations in test techniques, and so on.

Hitherto, PCR tests have led in terms of accuracy of results in diagnosing HSV. The other benefit afforded by PCR tests is that they can help diagnosticians identify HSV-1 and HSV-2 viral load. Cell culture tests are also accurate, but carry the risk of misdiagnosis if the skin lesion samples used for the test are in the process of healing. Antibody and antigen tests, on the other hand, are based on enzyme linked immunosorbent assays (ELISA). These tests, which use blood samples for testing HSV antibodies and antigens, are quick as well as accurate.

Download the Future Shares of Herpes Marker Tests: https://goo.gl/iE5fl2

Statistics from the Centers for Disease Control and Prevention (CDC) show a 16% prevalence of HSV-2 among people in the U.S., with the African-American female population being most widely affected. In Canada, the country’s Public Health Agency has found the prevalence of HSV-1 infection to be higher. Data also shows that about 70% developed countries have HSV-1 seroprevalence among adults; in underdeveloped countries, this rate is just short of 100%. However, despite this, it is the North America and European regions that lead the global herpes marker testing because of a higher percentage of seroprevalence among the population in the countries in these regions coupled with a high HIV patient population.

The report also profiles the following leading companies in the global herpes marker testing market: DiaSorin, Enzo Life Sciences, Roche, and Thermo Fisher Scientific.

Kidney Function Tests Evaluates how Well the Kidneys are Working

Kidneys are among the most vital organs of the human body. Kidneys acts as blood filters, reabsorbing the essential elements and removing the water-soluble waste products from the blood. Since, kidneys play such an important role, they require constant regeneration of dead nephrons and proper blood circulation to maintain healthy cell growth, due to which they are vulnerable to cancerous tumorsandmetastasis. The functional damage of the kidney isastoundingly common across the world, and its incidence is increasing progressively more. The symptoms which indicates a problem related to kidneys include high blood pressure, blood in urine,difficulty in urination, frequent urges to urinate, and swelling in the hands and feet due to a buildup of fluids in the body.

Kidney function tests, or renal tests have several categories, which includes concentration and dilution tests, clearance tests (provides an assessment of the filtration rate of the glomeruli, the principal filtering structures of the kidneys and whole renal blood flow),visual and physical examination of the urine, and determination of the concentration of numerous substances in the urine, notably glucose, phosphate, sodium, amino acids, and potassium, to help detect possible impairment of the specific kidney functions generally involved with their reabsorption.

It was stated by the World Health Organization in the past that more than 1.4 mn patients per year undergo renal replacement therapy. Additionally, the organization stated that this number is increasing by nearly 8% every year. At the same time, the global kidney function tests market may also be hampered by the growing number of restrictions related to healthcare expenditure and stringent regulatory pressure regarding the use of certain methods in kidney tests.

Globally, the factors driving the growth of kidney function tests market include increasing incidences and prevalence of chronic kidney disease worldwide, aging population,high incidence rate of renal fibrosis, and increasing number of individuals suffering from diabetes. Also, other complications such as high blood pressure is contributing towards the increasing incidence rate and prevalence of chronic kidney disease worldwide.Demand for kidney function tests is mainly driven by the presence of a large patient population suffering from renal disorders. According to the WHO, there are more than 1.4 million people worldwide, who undergo renal replacement therapy every year with the incidence rate of chronic kidney disease growing by approximately 8% annually.However, increase in overall stringent regulatory approvals and healthcare expenditure are some of the market-restraining factors that might hamper the growth of the kidney function tests market in future.

Importance of Kidney Function Tests: https://goo.gl/K8SfJ6

From a geographical perspective, the global kidney function tests market is led by North America, followed by Europe. Both regions have advanced in the global kidney function tests market owing to the higher prevalence of kidney-related issues and the presence of a fully established healthcare industry, complete with the latest infrastructure. This applies to the U.S. more than other countries.

 Some of the key categories in the global kidney function tests market are dilution and concentration tests, physical and visual examination of urine, and clearance tests. Apart from these, another common form of renal tests includes the assessment of urine to separate various minerals and other substances, such as sodium, phosphate, glucose, potassium, and amino acids. The key players in the global kidney function tests market are Pfizer Inc., ManRos Therapeutics, Endocyte, Inc., IC-Meditech, Plexxikon Inc., Eli Lilly and Company, Ipsen S.A., Kadmon Corporation, LLC, Otsuka Holdings Co., Ltd., Discovery Biomed, Inc., Baxter International Inc., Galectin Therapeutics, Inc., and F. Hoffmann-La Roche Ltd.

Clinical Assessment of Orbital and Ocular Diseases is done with Ophthalmic Ultrasound Systems

Ultrasound systems have become as indispensable in the field of ophthalmology as standard clinical assessment modalities such as slit lamp or indirect ophthalmoscopy, the standard means for evaluating the anterior segment of the retina. Ophthalmic ultrasound systems are an important candidate for imaging areas behind the retina and the iris, which even newer imaging techniques such as optical coherence tomography (OCT) cannot image.

In recent years, ophthalmic ultrasound systems have enjoyed an important role in the determination of the design of intraocular lenses and precise measurement of the anterior segment of the eye for a variety of refractive surgeries.

Early Problems for Ophthalmic Ultrasound Testing in the form of Incompatible Hardware

The first use of diagnostic ultrasound for assessing the eye was observed in 1956, when Mundt and Hughes used ultrasound for A-mode examination of patients with intraocular tumors and cases of in vitro enucleated eyes. A flurry of research and development activity followed, mostly in the U.S. and Europe, and ultrasound techniques for A-mode diagnosis, B-mode assessment, and biometry were soon developed.

Many early research activities also met with a lot of difficulties, such as the existing transducers being typically low-frequency and unfocused – not consistent with the required resolution for many ophthalmic fields of operation. Alignment and acoustic coupling with the eye requires careful attention, especially as minute mistakes in biometric measurements can lead to deformations. Thus, early ultrasound systems combined several techniques to form the final assessments: oscilloscopes were used for generating displays and photography was used for recording results, rulers were used to measure echo time intervals on the photographs, and biometric results were computed using the rulers. All this resulted in a lot of uncertainty in the results.

With time, however, the field of ophthalmic ultrasound systems has seen continuous improvement due to advancements in the field of imaging devices and other complementary instruments, particularly in the form of the introduction of high-frequency transducers.

Download the Key Points of Technological Innovations done in these Systems at:

https://goo.gl/zMHPJr

Currently, a variety of highly accurate ophthalmic ultrasound systems are available in the market. These systems fall into four categories: A-scan systems, B-scan systems, pachymeters, and ultrasound biomicroscopy (UBM). A variety of ergonomic options in these systems are also available, such as portable, on platform, fixed, and handheld.

With the rising prevalence of eye disorders such as age-related macular degeneration (AMD), glaucoma, and cataract, the demand for ophthalmic ultrasound systems has also increased in the past few years. The high demand for radiation-free ophthalmic imaging modalities is a key trend observed in the global ophthalmic ultrasound systems market.

According to the WHO, cataract was responsible for more than 50% cases of blindness across the globe in 2010. As the number of geriatrics increases across the globe, the prevalence of cataract and age-related macular degeneration (AMD) is expected to see a continuous rise in the coming years. This will provide significant growth prospects to the global ophthalmic ultrasound systems market. However, factors such as the high cost of these systems and high development cost owing to stringent government regulations influence the global market.

Global Ophthalmic Ultrasound Systems Market Highly Fragmented

 The global ophthalmic ultrasound systems market is fragmented to a high degree and features a vast number of numerous established as well as emerging businesses. Some of the key businesses in this market include Optikon 2000 S.p.A., Ellex Medical Lasers Ltd., Optos plc, Sonomed Escalon, Quantel Medical, and Reichert, Inc.

Rehabilitation Robotics has been a New Field of Investigation for Many Medical Researchers

The robotic rehabilitation and assistive technologies market accounts for rehabilitation robots and assistive technology robots. A robot is a mechanical and virtual intelligent agent that is guided by a computer program. A robot is an electromechanical machine which performs a task automatically or guided by a remote control. Robotics is the branch of technology which deals with the design, construction, operation and application of robots, while the field of research devoted to extending rehabilitation through the implementation of robotic devices is called Rehabilitation Robotics. A rehabilitation robot guides movement of a disabled person or elderly person with the intention of improving sensorimotor functions like arm, hand, leg and ankle. An assistive robot performs a task for the benefit of an elderly person or a patient with disability. These robotic devices are helpful for millions of people who desire to conquer the disability.

Robotic Rehabilitation and Assistive Technologies Market Segmentation

The global market for robotic rehabilitation and assistive technologies, on the basis of product type, has been segmented into assistive robots, prosthetics, orthotics, therapeutic robots and exoskeleton robotic systems. The global market for robotic rehabilitation and assistive technologies is also segmented as fixed base robots and mobile robots. Fixed based robots can be placed nearby a patient for medication, feeding and other tasks. Mobile robots can be used for mobility support and for fetching or carrying. During the forecast period from 2016 to 2024, worldwide market is poised to achieve significant growth as a result of growing application of robotic devices across the rehabilitation centers and healthcare facilities offering rehabilitation to patients suffering from physical disabilities such as spinal cord injury, cerebral palsy, rheumatoid arthritis and stroke.

Recent Advances in Rehabilitation Robotics: https://goo.gl/vehWxY

Robotic Rehabilitation and Assistive Technologies Market Drivers

Worldwide increasing elderly population along with growing prevalence of conditions such as spinal cord injury, cerebral palsy, rheumatoid arthritis, dementia and other age-related disabilities are playing a key role in driving the global market for robotic rehabilitation and assistive technologies. According to the Centers for Disease Control and Prevention, approximately 200,000 people are living with spinal cord injury in the U.S. and the annual incidence has been estimated at 15 to 40 new cases per million population, nearly 12,000 to 20,000 new cases in a year. The Centers for Disease Control and Prevention stated in November 2013 that approximately 52.5 million U.S. adults suffer from arthritis, nearly 23% of the total adult population. According to a U.S. based website called MyChild at CerebralPalsy.org, around 764,000 children and adults have cerebral palsy in the U.S. Of which, nearly 500,000 are aged below 18 years. Globally, the prevalence of dementia was estimated around 35.6 million in 2010 that is expected to reach approximately 65.7 million by 2030 and nearly 115.4 million in 2050. More than 50% of all people with dementia lived in developing and poor economy countries in 2010 which is expected to exceed 60% by the end of 2030. Such high prevalence of conditions is expected to drive the demand for rehabilitation robots and assistive robots across rehabilitation centers, hospitals and other healthcare centers. High cost of robotic devices is one of the major factors that is restraining the market growth, especially in countries with low and medium economy.

In terms of geography, the global robotic rehabilitation and assistive technologies market has been categorized into four major regions, namely, North America, Europe, Asia-Pacific and Rest of the World (RoW). North America and Europe represented the first and second largest markets for robotic rehabilitation and assistive technologies in 2013. It was mainly due to well established healthcare infrastructure of these regions.

Robotic Rehabilitation and Assistive Technologies Market Key Players

Intuitive Surgical Inc., Accuray, Inc., Mazor Robotics Ltd. and Health Robotics S.R.L. are some major players of this market.

Transcatheter Aortic Valve Replacement Does not Require Open Heart Surgery

Transcatheter aortic valve replacement is an innovative technology primarily utilized for treating aortic stenosis. One of the most common and most serious valve disease problems, Aortic stenosis is narrowing of the aortic valve, decreasing blood flow from the heart. Possible signs and symptoms of aortic stenosis include chest pain, fainting, and heart failure though most people do not develop symptoms unless the disease is advanced. Severe aortic stenosis limits the amount of blood that reaches the brain and the rest of the body. Transcatheter aortic valve replacement (TAVR) has been developed for those patients who are at high risk for surgery. Aortic stents are used for the treatment of abdominal aortic aneurysm (AAA) which is a weak area in the wall of abdominal aorta. To create new walls to the affected blood vessel interventional radiologist inserts a catheter and a graft in the patient’s artery with minimal incision. Through catheter the surgeon passes compressed stent to the aneurysm, which then opened up creating new walls in the blood vessel.

Rising patient awareness about the benefits of minimally invasive procedures such as less traumatic surgical experience, reduced hospital stay and faster recovery would meet the patients demand. Factors such as increasing number of minimally invasive surgeries, growing patient awareness and increase in screening and detection of AAA would boost the demand for transcatheter aortic valve replacement. Moreover, technological advancement in surgical procedures would also significantly raise the demand of transcatheter aortic valve replacement procedures. The global population is aging and increasing, especially in developed countries such as the U.S., Europe and Japan. It is expected that the global aged population would rise from 11% (760 million) in 2011 to 22% (2 billion) by 2050. Aging induces the minimally invasive surgical procedures which necessitates in the growing of endovascular procedures. Therefore, the fact that the world is aging acts as a driver for the growth of transcatheter aortic valve replacement market. However, high cost is considered as a constraint for the development of this market to some extent during the study period.

Get Details About the Transcatheter Aortic Valve Replacement: https://goo.gl/TG58TB

North America dominates the global market for transcatheter aortic valve replacement and is expected to grow at a moderate rate during the forecast period. The growth of the market in North America would be primarily attributed to introduction of technologically advanced and innovative products in the market. Europe held the second largest market share of the total transcatheter aortic valve replacement market. Factors such as more number of patients diagnosed with endovascular diseases, increasing number of endovascular procedures and launch of innovative products such as drug-coated balloons, chronic total occlusion devices and aortic stents would boost the demand for transcatheter aortic valve replacement in the European market. Asia-Pacific comprises countries such as Japan, India, China, New Zealand, South Korea, Australia and other Asia-Pacific countries. With increase in aging population there is an increase in procedure volumes in densely populated countries such as India and China. Increasing economic growth and improving healthcare facilities provides more number of patients access to healthcare facilities at an affordable rate. Growing number of elderly and obese population lead to an increase in the number of minimally invasive procedures performed, as these patients are more susceptible to transcatheter aortic valve replacement. Increasing awareness and demand for minimally invasive surgery and rising medical tourism in the Asian countries would also boost the demand for transcatheter aortic valve replacement in the Asia-Pacific market.

Transcatheter Aortic Valve Replacement Market Key Players

Major market players operating in the global transcatheter aortic valve replacement market includes Abbott Laboratories, Cook Group, Inc., Cordis Corporation, St. Jude Medical among others.

Industry of Surgical Dressings – Provider of Mechanical and Bacterial Protection on Wounds

Wound dressing market is booming worldwide due to modern technologies that are being used in healing the wound. Gauze tapes, sponges, and surgical cotton swabs are some of the fast healing surgical dressings. Absorbent and packing gauze is a cotton fabric of various thread counts and weights, and is widely used in wound dressing. Wound dressing is the process of wound packing in order to prevent microbial infection and spreading of necrosis. Wounds are injuries to tissue such as cuts, scratches, punctured skin and scrapes, and is usually caused by accidents, burns and physical activities such as sports. Absorbent gauze is sometimes recommended to be placed on deep wounds where it promotes healing by preventing abscess formation. Absorbent and packing gauze is supplied in various sizes (lengths and widths) and forms (rolls and folds).

Growth of Surgical Dressing Market

The market for absorbent and packing gauze surgical dressings is expected to grow worldwide owing to factors such as increasing incidences of road accidents and sports related injuries. Globally rising aging population and the growing prevalence of chronic diseases. In addition, the swift healing times brought about by the usage of wound dressings make them useful during emergency care. The rising incidence of wound infections raises the sale of wound dressings, thus having a positive impact on the market.

Development of new and innovative products will also contribute in driving the market growth in coming years. Geographically, North America and Europe are the leading markets for absorbent and packing gauze surgical dressings. In Europe, EU-5 countries (Germany, France, U.K., Italy and Spain) offers immense opportunities to companies operating in the absorbent and packing gauze surgical dressings market. However, over the past few years, Asia-Pacific has been the fastest growing region for absorbent and packing gauze surgical dressings market, mainly due to emerging economies of India, China and Taiwan.

The rising healthcare expenditure and growing awareness amongst patients about the benefits of wound dressings will also stimulate the market for wound dressings in the coming years. On the other hand, factors such as the soaring cost of advanced wound dressings may restrain demand within a number of Asian markets, thus having a negative impact on the overall market.

It is Important to Understand the Insights of Surgical Dressings: https://goo.gl/b10rJW

Surgical dressing: Key players

The market for absorbent and packing gauze surgical dressings is largely fragmented between domestic and multinational companies. In many Asian countries like India and China, local players supply these products at very low prices than multinationals and thus create intense price war among the players. Smith & Nephew Pty Ltd., Medline Industries, Inc., Covidien Ltd., UDL Laboratories, Inc. and ConvaTec, Inc. have been identified as the major players operating in the absorbent and packing gauze surgical dressings with a global presence.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

Acute Care - A Branch of Secondary Healthcare which Provides Short Term Treatment to Patients

Acute care is a branch of secondary health care in which short term treatment is provided to patients for their various medical conditions such as severe injury and recovery from surgery. Acute care medical services are usually provided to patients by health care professionals including medical and surgical specialties. Acute care may necessitate stay of a patient in hospital emergency department and ambulatory surgery center. Hospital-based acute inpatient care typically has the goal of discharging patients as soon as they attain healthy and stable medical condition. Usually acute care settings include emergency department, coronary care, intensive care, neonatal intensive care and cardiology.

Acute care market segmentation

Based on the medical condition of the patients, acute care services can be segmented as emergency care, urgent care, short term stabilization, pre-hospital care, critical care, trauma care and acute care surgery. According to Heart Foundation projected that Cardiovascular Disease (CVD) is the leading global cause of death, accounting for 17.03 million deaths per year. It projected that the number will grow to more than 23.06 million by 2030.

The market for acute care is expected to show tremendous growth rate throughout the forecast period 2014 to 2020. The rising number of elderly people across the globe is one of the many reasons for acute care market growth as they usually suffer from various acute diseases such as viral infection and cardiovascular diseases. In addition, increasing number of hospital owing to rising healthcare expenditure would further drive the growth of acute care market. Large revenue contribution of the region is due to the presence of large number of patient population. In addition, presence of large number of hospitals and ambulatory surgery centers in the region further propels the growth of acute care market. Likewise, large number of emergency visits in hospitals across North America due to huge incidences of trauma injury has also contributed heavily in collecting largest share of the global acute care market. Europe accounted for the second largest share of global acute care market owing to presence of significant number of patient population.

Download Futuristic Trends of Acute Care Treatment at: https://goo.gl/RCnDm2

The acute sector is involved in two types of vanguards; sites that encourage the spread of excellence between hospitals covering over 15 million people, and sites that focus on integrated care between different services and local areas.

Acute care market growth

According to the World Health Organization, around 80 percent of the total CVD deaths occur in developing countries. These unmet medical needs of the population in emerging economies will support the growth acute care market. In addition, increase in healthcare infrastructure and medical expenditure by the governments in Asia-Pacific will also increase the number of medical institutions such as hospitals that would provide acute care services. Likewise, rise in healthcare expenditure will also widen the entry of acute care service provider in the market. For instance, it has been estimated that China’s healthcare expenditure was USD 357 billion and is expected to reach USD 1,000 billion in 2020.

Abnormal Level of Biochemical in the Body causes Appetite Disorders

Although it is not a new disease, an appetite disorder can be related to modern lifestyle. In an attempt to reduce the weight and bring the body into shape people tend to decrease the normal food consumption. It is largely explained as a disturbed eating habit or disorders leading to significant impairing of physical and psychological health of the patient. Eating disorder also occurs with variety of other psychiatric illnesses such as substance abuse, anxiety disorder, depression and other similar conditions. In addition, people suffering from appetite disorders can experience a wide range of physical health complications such as serious heart conditions and kidney failure among others which may lead to even death.

Appetite disorder market: Categories

Two of the prominent categories of the eating disorders include anorexia nervosa and bulimia nervosa. In anorexia nervosa, people tend to starve themselves for extreme weight loss whereas in bulimia nervosa a person tend to vomit after having food more than a stipulated amount every time. Females are more prone to eating or appetite disorders as compared to men. According to an article published in Psychology Today, approximately 0.5% to 3.7% of the female population suffers from anorexia nervosa whereas, an estimated 1.1% to 4.2% of the female population have bulimia nervosa in their lifetime. In the United States approximately 7 million women and 1 million men suffer from appetite disorder

Appetite disorder market: Major drivers

Major drivers to appetite disorder include genetics, abnormal level of biochemical in the body, psychological and environmental factors. With respect to genetics, identical twins are more likely to have higher rate of eating disorder as compared to fraternal twins or other siblings. Stress is another prominent cause of eating disorders. Many research studies have found that patients suffering from bulimia and anorexia have considerably higher level of stress hormones such as cortisol and serotonin. Environmental factors such as family and relationship problems, sexual abuse, disturbed childhood and peer problem can also significantly contribute towards appetite disorders. Despite of all these findings till date, the exact cause of the eating disorders is still unknown.

Get Healthcare Aspects of Appetite Disorders: https://goo.gl/o8972w

Appetite disorder market: Available drugs

Available treatment for appetite disorder includes nutritional therapy and drug therapy. Some of the commonly used drugs include antidepressants, antipsychotics, calcium plus vitamin D supplement and gastrointestinal stimulants among others. Lack of awareness about the disorder and absence of professional help in developing economic countries are some of the key restraints to the uptake of appetite disorder market. Cultural, professional and social compulsions such as requirements in the entertainment industry, modeling and a blurred perception of what a healthy body should look like has been a major cause of anorexia and bulimia. Several not-for-profit organizations have been creating awareness of the problems caused by social perceptions and demands in society for having a thin body particularly in females. This was conventionally upheld as a parameter for visual appeal, but is now slowly changing, with reducing number of cases over the world.

Appetite disorder market: Affected regions

Geographically, developed economic countries such as the United States and Europe are more prone to appetite disorder as compared to developing economic region primarily due to unhealthy eating habits and lifestyle related disorders. Intense research and development and awareness among people regarding eating disorder in developed economic countries are another contributing factor for increase in revenues in these two geographic regions. Many companies such as GlaxoSmithKline plc, Medisyn Technologies, Inc., Omeros Corporation are conducting rigorous clinical trial activities to develop novel drugs for patient suffering from appetite disorders. Asia-Pacific and Rest of the World are one of the fastest growing region owing to increase in disposable income, increasing influence and impact of camouflaging western culture lifestyle and rising incidences of obesity related disorders among mid-aged people.

 Some of the prominent companies operating in Appetite (Eating) Disorders Market include GlaxoSmithKline plc, INSYS Therapeutics, Inc., Global Health Ventures Inc., Omeros Corporation, Kuhnil Pharmaceutical Co., Ltd., Medisyn Technologies, Inc., Lightlake Therapeutics Inc. among other players.

Postmenopausal Hormone Therapy Comprises of Natural as well as Synthetic Estrogens

Postmenopause is the period occurred after menopause followed by various syndromes like vaginal dryness, hot flashes, etc. During this period level of estrogen and progestin falls significantly leading to even serious complications like osteoporosis. The worldwide market for Postmenopausal Hormone Therapy is gaining moment substantially. This rising demand for Postmenopausal Hormone Therapy is due to increasing level of awareness about menopausal symptoms and its treatment. Another factor is growing population of post-menopausal women. Postmenopausal Hormone Therapy includes replenishment of body level of estrogen and progestin hormones in women through external intake of hormones. Thus, it help in treating the menopausal symptoms. It decreases the symptoms like vaginal dryness, hot flashes, disturbed sleep, night sweats and etc. The Postmenopausal Hormone Therapy helps in prevention of osteoporosis and hot flashes caused due to depletion of estrogen and progestin level in body. The Postmenopausal Hormone Therapy comprises of natural as well as synthetic estrogens. In order to enhance the menopausal treatment, it is also given in combination with progesterone.

The recent developments in postmenopausal hormone therapy have led to the introduction of advanced and safe therapies. The increasing funding from governments of many nations have also contributed towards the introduction of new therapies, which is another factor boosting the global postmenopausal hormone therapy market. The non-hormonal treatment comparatively has least efficiency to produce required results, which is why the demand for postmenopausal hormone therapies is expected to increase in the years to come.

Download Important Structure for Postmenopausal Hormone Therapy: https://goo.gl/tJ9mzk

However, the cost of this therapy is the key factor expected to hamper the growth of the global postmenopausal hormone therapy market. The yearly cost of the postmenopausal hormone therapy is approximately US$10,000, which is slightly on the higher side as compared to the non-hormonal therapy. The post-therapy risks and complications are expected to further challenge the growth of the global market.

Key companies are working on introducing new postmenopausal hormone therapies at affordable prices, which is expected to propel the global market in the long run. The global postmenopausal hormone therapy market is segmented on the basis of region, end user, product, dosage form, therapy, and route of administration. Patches, creams, tablets, suppositories, and injections are some of the products of postmenopausal hormone therapy.

Abbott Laboratories, Bayer Pharma AG, Novo Nordisk A/S, AbbVie, Inc., and Hisamitsu Pharmaceutical Co., Inc. are some of the key companies operating in the global postmenopausal hormone therapy market.

Rising Stressful Life Rises Incidence of Panic Attacks to fuel Demand for Panic Attack Treatment

Panic attacks are associated with sudden episodes, of emotions of fear and anxiety. It is a type of anxiety disorder, and other anxiety disorder includes generalized anxiety disorder, obsessive-compulsive disorder (OCD), Posttraumatic stress disorder (PTSD), social anxiety disorder, and special phobias.Generally, panic attacks are not life threatening but they can be frightening and significantly affect the quality of life. Symptoms of the panic attack may vary from person to person, and intensity of attack. In general, symptomsincludes sense of danger, intense fear of loss of control or death, hot flashes, chills, chest pain, sweating, and feeling of detachment. Major risk factors for panic attacks are genetics, major stress due to changes in a life, or traumatic event, and certain changes in brain functioning. According to World Health Organization (WHO), females are at higher risk of panic attacks than males. Panic attacks left untreated, further may link to the depression, anxiety disorders, and psychiatric disorder, suicidal thoughts, and substance abuse. Treatment can help to reduce frequency, and intensity of panic attacks to improve the quality of life. Treatment recommended for panic attacks include psychotherapy (talk therapy), and medications. Psychotherapy generally considered as a first choice of the treatment.

Besides the growing prevalence of stressful living, the market also has a strong pipeline, which is aiding its growth. The Anxiety and Depression Association of America, considers anxiety disorders one of the most common illnesses in the U.S. affecting a sizeable 11% of its population. Additionally, over 2.7% of the U.S. population or roughly 6 million people in the country face anxiety issues triggered by panic attacks.

Despite such high incidence of anxiety, which ideally should have provided the market with momentum, poor diagnosis rate is impeding its trajectory. Besides this, concerns regarding the side effects of medications such as dry mouth, nausea, and habit forming nation could hinder the market’s growth to an extent. However, the capitalizing on untapped opportunities in emerging economies could help companies mitigate these challenges.

Download Important Notes Regarding Panic Attack Treatment: goo.gl/O0bx8D

For the purpose of the study, the global panic attack treatment market can be segmented based on geography, drug, and class. By drug class, the market is segmented into serotonin norepinephrine reuptake inhibitor (SNRI), selective serotonin reuptake inhibitor (SSRI), and benzodiazepines (BZD). Of these, SNRI and SSRI are considered as the first line therapy to be administered to panic attack patients, hence they exhibit clear dominance in the global panic attack treatment market.

The regional segments of the market comprise Europe, Asia Pacific, Latin America, North America, the Middle East and Africa, and Rest of the World. Among these regions, North America emerged dominant in the global market due to the rising incidence of panic attacks witnessed in the region. The high awareness among people related to anxiety disorders and the potential treatment also supports the market’s growth in North America. However, TMR projects the Asia Pacific market to report faster growth during the forecast period.

 Some of the key players operating in the global panic attack treatment market are Actavis Pharmaceutical Company, Abbott Laboratories, Bristol-Myers Squibb, Baxter International, GlaxoSmithKline Pharmaceuticals Limited, Eli Lilly and Company, Pfizer,Inc., F. Hoffmann-La Roche, Sumitomo Dainippon Pharma, Noven Pharmaceuticals, Inc., Shionogi and Company, and Recordati Rare Diseases.

Healthcare Databases have Cloud-Based Implementations for Faster Response Times

Cloud computing is one of the major modern trends being followed in almost all industry verticals. Adopting cloud technology allows an organization to be faster, more efficient, and in a position to use high-end software, which can rapidly increase output. The use of cloud computing in healthcare is highly diverse and currently in a formative stage, where the use of modern technology is creating a large scope of growth for this market. Cloud computing can offer a unique advantage to most verticals – that of being relatively low-cost while still giving access to high-end software and storage options to help speed up processes.

Details About Healthcare Cloud:

http://www.transparencymarketresearch.com/healthcare-cloud-computing.html

The competitive landscape of the global cloud computing market in the healthcare industry is crowded by the presence of a large number of players. The presence of a large number of participants has led to the fragmented nature of the market. Some of the major players operating in the global cloud computing market in the healthcare industry are Cisco Systems Inc., Carestream Health Inc., Carecloud Corp., AGFA Healthcare, IBM Corp., Cleardata Networks, Merge Healthcare Inc., Microsoft Corp., Intel Corp., and Oracle Corp

Concerns About Data Leakage is a Major Challenge for Market Players

Rapid transformations in the healthcare IT sector, coupled with the growing demand for security of access and data integrity have supported the growth of cloud computing in the healthcare industry. “An increasing number of companies are reducing investments in the creation and maintenance of a physical IT infrastructure and are shifting towards cloud computing for easier management of profiles,” states TMR.

However, data relocation from established systems is a major hiccup in the market’s growth during the forecast horizon. Data integration and consistency is also another challenge faced by the market players. The growing concerns pertaining to data leakage have made a number of healthcare providers apprehensive about the adoption of the cloud computing technology. The market players are focusing on the introduction of wireless technologies in cloud computing solutions to allow remote access of data on a real-time basis. The increasing usage of ACOS for data sharing through mobile devices has created ample opportunities for the growth of the market players.

PaaS to be Largely Preferred by the Healthcare Industry

Among the major service models, the Platform-as-a-Service (PaaS) model is expected to register the highest demand. “Simple application and high rate of deployment are the primary factors driving the demand for the PaaS model,” states TMR. The PaaS model does not rely on hardware and software and offers support within the service’s lifecycle. Though the market was dominated by the IaaS model in 2011, PaaS is anticipated to generate more revenue in the years to come.

Download the Discussions Regarding this Technology: http://bit.ly/2cj3zj7

The global cloud computing market in the healthcare industry is projected to expand robustly at a CAGR of 21.30% during the period between 2012 and 2018. The market was valued at US$1.82 bn in 2011 and is anticipated to be worth US$6.79 bn by 2018.

In terms of service model, the report expects most consumers to prefer PaaS cloud computing as it offers the greatest number of advantages to the healthcare industry. PaaS cloud computing holds rapid deployment speeds and simple application, allowing it to be used on a wider scale than other service models. Additionally, PaaS cloud computing does not entail software or hardware reliance for the client, as the service provider can offer both.

The report also describes the numerous public, private, and hybrid cloud services in the market and how they affect the global cloud computing market in the healthcare industry.

From a geographical perspective, the global cloud computing market in the healthcare industry was dominated by North America in 2011. The report expects North America to continue leading this market for the given forecast period, while Europe and Asia Pacific follow closely.

Healthcare Electronic Data Exchange - A Systematic Application of EDI in the Field of Healthcare

Electronic Data Interchange, abbreviated as EDI, is an innovative electronic communication technology, that offers exchange data standards, for exchange of data by any kind of electronic technology. Electronic data exchange permits exchange of important data between two or more companies, situated in two or different countries, by application of certain standards of EDI. EDI can be defined as, exchange of data, by using predetermined message terms and standards, from one computer device to another, without any human or mechanical intervention. Electronic data exchange was launched by National Institute of Standards and Technology in 1996.

The tremendous expansion of the technological scenario and its applications in the healthcare market is one of the major factors that is driving the overall healthcare EDI market. In addition, the increasing incidence of chronic diseases and several other disorders and rising awareness regarding a healthy lifestyle are other factors that are expected to fuel the growth of the global healthcare EDI market through the forecast period. The high growth rate of the global market is further supported by research and development activities, increasing clinical trials, the growing base of end users including private players and hospitals, and increasing emphasis on insurance claims and reimbursement. As a result, in recent years, time and money that was wasted in healthcare management have been saved tremendously, resulting in the growth of the overall market.

On the other hand, limited technological access in underdeveloped and rural areas across the globe and the risk of loss of system database are some of the major factors that are estimated to hamper the growth of the global healthcare EDI market in the next few years. In addition, financial limitations are also acting as a major restraint on further penetration of healthcare EDI.

Furthermore, the global healthcare EDI market has been segmented on the basis of end use into pharmacies and medical devices, suppliers and distributors, healthcare service providers, equipment manufacturers, and healthcare financers including private and government financers. The healthcare service providers segment is further sub-segmented into clinics, medical infrastructure, hospitals, and other medical assessment centers. On the basis of geography, the market has been divided into Asia Pacific, North America, Europe, and Rest of the World. The market shares and estimates of every segment have been discussed in the scope of the research report.

Download Insights of Technical Advancements in Healthcare EDI: http://bit.ly/2cvR7sg

The research study further covers the competitive landscape of the global healthcare EDI market, providing insights into company profiles, inception details, contact information, business policies, financial overview, mergers and acquisitions if any, and SWOT analysis. Some of the prominent players operating in the global healthcare EDI market are Optum Inc., Passport Health Communication, GE Healthcare, Ssi Group, Siemens Healthcare, and Capario Inc.

Innovative Technologies to Propel Growth of Digital Wound Measurement Devices Market

Wound is defined as a disruption in the continuous structure of the skin, which may at times extend to internal layers lying deep below the skin. Traditionally wound was defined as any bleeding of extremities or vital organs visible from outside, modern science has currently included the occurrence of internal wounds within the definition of wound. The nature of a wound may vary from simple abrasion, to complex tissue damage. Wound care is therefore often dependent upon the nature of the wound and its location. In some cases wound area needs to be understood in order to provide adequate care to the region. This provides a basis for the application of wound dressing in terms of material required and at the same time measures the progression of wound healing process. Besides being a mandatory practice to study the progress of wound healing, wound measurement and regular tracking of wound size is integral in terms of insurance coverage, litigation and reimbursement. Wound measurement devices were initially surgical scales and rulers. These are now described as simple devices and are considered as crude or inaccurate, although they are still in use in many countries worldwide.

Simple devices use the concept of rectangular or quadrilateral area (l*b*0.785) calculation measured with the help of conventional rulers or scales. Another way to measure wound is by using a transparency sheet to outline the area which can be later measured in an area grid map. Complex devices are expensive and are more accurate in comparison to simple devices. Complex devices include optical instruments such as stereophotogrammeter (SPG) or structured lighting to obtain wound images which can be later on rendered by a computer to make a 3D image for further study and monitoring of the wound care. Wound measurement devices are yet in the developing stages with new innovations arising every year. However, common conclusion is that novel complex technologies are better in monitoring progress and examining the wound coverage area. Wound care has seen a great quantum of development in the present ages with the assistance from wound measurement devices. Hand held computers and smart phones are now being integrated using both simple and complex techniques to get a complete solution. Laser based wound terrain identification technology is also under development that shall monitor real time 3D image of the wound and its healing rate. The software program that develops photo-digital planimetry with its PictZar Digital Planimetry Program Software, a product of BioVisual Technologies, LLC, Elmwood Park, NJ. It is capable to load in the surface area of the wound without depending on a drawn perimeter.

Download the Industrial Forecast of Digital Wound Measurement Devices at:
http://bit.ly/2dloMv0

The report studies the digital wound measurement devices market across four key regions: Asia Pacific, North America, Europe, and Rest of the World. In 2013, North America dominated the overall market, with the U.S. alone accounting for 40-50% of the market. Europe was the second largest region in the market. However, Asia Pacific witnessed a rapid increase in sales of digital wound measurement devices in the same year. The growth rate of this regional market was higher than North America and Europe. The growing prevalence of skin cancer among the geriatric population in countries such as Japan, India, and China has contributed towards the growth of the digital wound measurement devices market in Asia Pacific. During the forecast period, the Middle East holds the highest potential for market growth owing to the presence of a large number of diabetic patients across Kuwait, Saudi Arabia, and Qatar.

 The report profiles some of the prominent players in the global digital wound measurement devices market such as Derma Sciences Ltd, Smith & Nephew PLC, and Medline Industries Inc. 

Introduction of Mobile Healthcare has Greatly Influenced Medical Science

The introduction of a wide range of portable handheld devices has substantially influenced various fields; medical science being one of them. Healthcare professionals from medical centers and hospitals use various kinds of portable handheld devices to offer point-of-care services to the patients. The handheld devices sector in the healthcare market has witnessed a steady growth in the past few years and is expected to witness rapid development in the near future. The development of highly precise and portable handheld devices has led to the growth of the global handhelds in the healthcare market in the recent past.

With the union of advanced technologies including cloud-based mobile healthcare services with the handheld equipment, it is anticipated that the global handhelds in healthcare market will register a significant growth during the forecast period. The commonly used handheld devices in the healthcare market are categorized into patient information management devices and patient monitoring devices. Personal digital assistants, smartphones, and tablet computers are some of the popularly used patient information management devices. Pulse oximeters, electrocardiogram (ECG/EKG), multiparameter monitors, fetal heart monitors, continuous glucose monitors, blood pressure monitors, portable ultrasound devices, and others are some of the handheld patient monitoring devices used in the healthcare market.

By end user, the global handhelds in healthcare market is classified into hospitals, pharmacies, ambulatory care centers, home healthcare, and nursing homes. The global handhelds in healthcare market is highly competitive and fragmented due to the presence of many well-established players and new entrants. The growing demand for portable and mobile handheld devices is expected to propel the global handhelds in healthcare market in the forthcoming years. Some of the leading companies in the global handhelds in healthcare market are Apple, Inc, GE Healthcare, Hewlett-Packard Development Company, L.P., Motorola Solutions, Inc., Siemens Healthcare, Welch Allyn, Inc., BlackBerry Limited, Honeywell International Inc., Medtronic plc, Omron Corporation, and Socket Mobile.

Get Free Aspects of Mobile Healthcare Professional trends at: http://bit.ly/2cEwBZM

Based on geography, the global handhelds in healthcare market is segmented into Asia Pacific, Europe, North America, and Rest of the World. Currently, the global handhelds in healthcare market is dominated by North America, followed by Europe. The high adoption rate of portable handheld devices in the healthcare market helps North America to be the leader in the global handhelds in healthcare market.

As per the World Health Organization (WHO), the global elderly population is expected to reach 2 billion by 2050, which was 524 million in 2010. As per the United Nations, the population of people aging 60 years and above is expepected to rise from 841 million in 2013 to more than 2 billion by 2050. The rising aging population and advancements in handheld devices are predicted to contribute further towards the growth of the global handhelds in healthcare market during the forecast period.

Due to the high rate of adoption of portable and mobile handheld devices in healthcare services in Asia Pacific, this region is expected to emerge as lucrative market for handhelds in the healthcare sector during the forecast period.

Primary Care Physician -A First Medical Practitioner Contacted by a Patient

Primary care doctors are the licensed healthcare professionals who diagnose and treat individuals, and help them in restoring their health condition, and thus bring them back to the active life through reducing the physiological complications and restoring the body functions. They are the primary point of advice for the patients due to a number of factors like easy communication, familiarity and the need of cost management. They may refer the patients to a specialized care for the further treatment process. They prescribe a particular diagnosis for the patient and interpret results from it, and thus they formulate a plan, a medication, therapy, referral to specialist and follow-up the results of treatment. Primary care doctors are present in hospitals, private practices, outpatient clinics, home health agencies, and nursing homes. The activities by the doctors in the industry includes examining the patient’s history, designing the technique or management plan, incorporating the results and providing therapy and education.

Based on various types of treatment, the Primary care market can be segmented as follows:

> Family Medicine Doctors: They are board certified to check-up people of all ages.

> Internal Medicine Doctors: They check-up people above 14 years of age. They check internal organs of the body and prescribes medicine for it. Some of them can also provide care for gynecology and dermatology.

> Gynecologist or Obstetrician: These physicians provide special care to the women during and after the reproductive phase. Almost all Gynecologists have specialty in Obstetrics.

> Geriatricians: These physicians have special education to treat adults over 60. They provide medication management and mental assessment related falls and other aging issues.

> Pediatricians: There are certified to diagnose and treat children from newborn through age 21, through a wide range of diseases.

Download the Exceptional Services of Primary Care Physician at: http://bit.ly/2cLH1qe

Some of the major driving factors for the market growth include rising aging population and increasing prevalence of chronic health conditions. Due to the federal healthcare reform, there is high rate of private insurance which made the private healthcare services much affordable for the U.S. population.

The key regional markets studied in the report include: North America, Latin America, the Middle East, Europe, Asia Pacific, and Rest of the World. North America is identified as the leading region in the primary care doctor market, while Europe is the second-largest market. A number of favorable reforms recently introduced in the United States will augur well for the lead that North America currently has in the primary care doctor market. As more people in the United States strive to maintain a healthy lifestyle well into their 70s and 80s, the role of primary care physicians becomes even more crucial. In 2015, in the United States, about 176,893 primary care physicians were licensed to practice internal medicine.

Multiple emerging economies in the Asia Pacific region will contribute heavily to the creation of a multimillion-dollar primary care doctor market in the region. However, the primary care doctors market in the Asia Pacific region will benefit from the relatively affordable level of care offered by physicians here and the setting up of new medical infrastructure that will

However, restraints such as an erosion in the quality of care and misdistribution will create challenges for the growth of the primary care doctor market. The report on the primary care doctor market provides a detailed analysis of the current and projected landscape of the primary care doctor market globally and for leading national markets. 

Health Insurance Industry is one of the Cardinal Components of the Global Economy

The concept of health insurance, in general, is objectively simple wherein an individual or organization purchase services or plans to avoid their risk in event of un-avoidable health conditions. Health Insurance provides financial security to the people in their health care needs. The health insurance industry is one of the cardinal components of the global economy by virtue of the amount of revenue it collects, the extent of the global investment, and most prominently the indispensable socio-economic role it plays by securing personal and business risk in the event of an unforeseen problems.

Transparency Market Research’s report, titled “Health Insurance Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023”, examines the market through a microscopic lens to get a detailed understanding of various facets of the global health insurance market. It also presents historical data pertaining to the healthcare insurance industry and correlates it with the forecast to help readers in building a framework of the market’s trajectory.

The global health insurance market is growing by leaps and bounds, contributing significantly to the global economy. Health insurance can be purchased individually or by companies for their employees to offer heath care coverage. In an individually purchased health insurance, the out-of-pocket spending is far more than group insurance purchases. The premium is higher in the individual market, as the buyer pays the full premium without any contribution from the employer.

The most obvious benefit of health insurance is the financial security it provides to the patient in the event a health-related expense arises. The remarkable growth of the health insurance market in the past few decades has made it the spinal cord of the global economy, as it collects mammoth amounts of revenue. The healthcare industry also plays a vital role in determining the global investments and securing lives of many, thereby keeping the socio-economic structure balanced.

In 2014, as the global economies stabilized, limping back to normalcy after an economic downturn, the disposable incomes and GDPs showed notable improvements. As the high income groups and middle class were equipped with more financial resources, both the groups were seen investing in healthcare insurance for safeguarding themselves against unforeseen problems. This trend is expected to augment the global health insurance market in the coming years as well.

Download the Future Vision of Health Insurance Industry: http://bit.ly/2d5cjrZ

In the coming years, insurance companies and investment firms will adopt digitalization of business process to reach out to a wider audience across all boundaries. Furthermore, the impactful business and marketing strategies, transparency in operations, and simplification of products by insurance companies is also expected to win them new clientele.

Some of the important players profiled in the global health insurance market are UnitedHealth Group Inc., Allianz SE, Cigna Corporation, Express Scripts Holding Company, AIA Insurance Group, Zurich Insurance Group Ltd., AXA, Aetna, Inc., International Medical Group, Aviva plc, and Apollo Munich Health Insurance. The research report offers an insight into the competitive landscape of the global health insurance market along with presenting details regarding companies’ financial overview, research and development activities, investment outlook, and business and marketing strategies. The report also assesses the companies using a SWOT analysis and a Porter’s five forces analysis to highlight the key elements impacting them.